Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-506
Closed -$114K 226
2021
Q4
$114K Buy
506
+450
+804% +$95K 0.05% 55
2021
Q3
$11.9K Hold
56
0.01% 166
2021
Q2
$13.7K Hold
56
0.01% 130
2021
Q1
$13.9K Hold
56
0.01% 122
2020
Q4
$12.9K Sell
56
-45
-45% -$10.4K 0.01% 106
2020
Q3
$25.7K Hold
101
0.02% 66
2020
Q2
$23.8K Buy
101
+45
+80% +$10.3K 0.02% 66
2020
Q1
$11.4K Hold
56
0.01% 80
2019
Q4
$13.5K Buy
+56
New +$12.3K 0.01% 103

Other funds holding AMGN

Halpern Financial's AMGN Position: Q1 2022 in Review

Halpern Financial sold out of Amgen (AMGN) in Q1 2022, closing a stake of 506 shares — an estimated $114K sold.

Halpern Financial first reported a position in AMGN in Q4 2019 and held it in 9 quarters. The position peaked at $114K in Q4 2021. 2,338 funds tracked by Wall St. Rank hold AMGN as of Q1 2022.

  • Halpern Financial reported no remaining Amgen position as of Q1 2022 after selling out during the quarter.
  • Halpern Financial sold 506 Amgen shares in Q1 2022, an estimated $114K.
  • Halpern Financial first reported a position in Amgen in Q4 2019 and held it in 9 quarters.
  • Halpern Financial's Amgen position peaked at $114K in Q4 2021.
  • 2,338 funds tracked by Wall St. Rank held Amgen as of Q1 2022.

Based on Halpern Financial's 13F filing for Q1 2022, filed 21 Sep 2023.